Quick Answer
PAVmed Inc. reported Total Revenue of $71.0 thousand for the year ending 2025.
- PAVmed Inc. showed a decrease of -97.6% in Total Revenue from 2024 to 2025.
- This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $200.0 thousand | Q1 2022: $189.0 thousand | Q3 2022: $76.0 thousand | Q1 2023: $446.0 thousand | Q2 2023: $166.0 thousand | Q3 2023: $791.0 thousand | Q1 2024: $1.01 million | Q2 2024: $979.0 thousand | Q3 2024: $996.0 thousand | Q1 2025: $8.0 thousand | Q2 2025: $6.0 thousand | Q3 2025: $5.0 thousand.
- Over the full 5 years of available data (2021 to 2025), PAVmed Inc.'s Total Revenue has declined by 85.8%.
- Historical annual values: Fiscal year 2025: $71.0 thousand | Fiscal year 2024: $3.00 million | Fiscal year 2023: $2.45 million | Fiscal year 2022: $377.0 thousand | Fiscal year 2021: $500.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: